Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study

NCT00876512 is registered in ClinicalTrials.gov with Kumamoto University as lead sponsor.

NCT NCT00876512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00876512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study
Lead sponsor
Kumamoto University
Phase
Observational
Overall status
Completed
Start date
December 31, 2008
Completion date
September 30, 2010
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stable angina